江苏康宁杰瑞生物制药有限公司
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Alphamab Oncology is Invited to Present at the 37th Annual J.P. Morgan Healthcare Conference 2019-01-04 17:02
Alphamab Oncology Completes Series-A Round Financing - Further Strengthening Its Global Innovative Biologics Platforms 2018-11-17 00:12
KN035, a Global Leading Subcutaneously-administered PD-L1 Antibody, Starts Late-stage Clinical Development 2018-10-23 19:03
Alphamab Oncology's HER2 bispecific antibody KN026 gained US IND approval; phase I clinical trial started in China 2018-10-16 18:18
Alphamab Oncology's first-in-class PD-L1 - CTLA-4 bispecific antibody enters clinical trial 2018-10-10 18:36
1 2 3 4